VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2019

Apr 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2019-04-16

Reporting Person: Parini Michael (EVP, CL&AO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-16	Common Stock	M	4250	$122.45	Acquired	39253	Direct
2019-04-16	Common Stock	S	870	$179.91	Disposed	38383	Direct
2019-04-16	Common Stock	S	815	$181.31	Disposed	37568	Direct
2019-04-16	Common Stock	S	1605	$182.19	Disposed	35963	Direct
2019-04-16	Common Stock	S	300	$183.26	Disposed	35663	Direct
2019-04-16	Common Stock	S	660	$184.44	Disposed	35003	Direct
2019-04-16	Common Stock	M	2125	$90.29	Acquired	37128	Direct
2019-04-16	Common Stock	S	425	$179.84	Disposed	36703	Direct
2019-04-16	Common Stock	S	600	$181.49	Disposed	36103	Direct
2019-04-16	Common Stock	S	600	$182.24	Disposed	35503	Direct
2019-04-16	Common Stock	S	100	$183.15	Disposed	35403	Direct
2019-04-16	Common Stock	S	400	$184.42	Disposed	35003	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-16	Stock Option (Right to Buy)	$122.45	M	4250	Disposed	2026-01-03	Common Stock (4250)	Direct
2019-04-16	Stock Option (Right to Buy)	$90.29	M	2125	Disposed	2026-07-11	Common Stock (2125)	Direct

Footnotes

F1: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.

F2: Open market sales reported on this line occurred at a weighted average price of $179.91 (range $179.68 to $180.55).

F3: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4: Open market sales reported on this line occurred at a weighted average price of $181.31 (range $180.82 to $181.67).

F5: Open market sales reported on this line occurred at a weighted average price of $182.19 (range $181.84 to $182.67).

F6: Open market sales reported on this line occurred at a weighted average price of $183.26 (range $183.13 to $183.48).

F7: Open market sales reported on this line occurred at a weighted average price of $184.44 (range $184.18 to $184.71).

F8: Open market sales reported on this line occurred at a weighted average price of $179.84 (range $179.63 to $180.30).

F9: Open market sales reported on this line occurred at a weighted average price of $181.49 (range $180.97 to $181.95).

F10: Open market sales reported on this line occurred at a weighted average price of $182.24 (range $182.06 to $182.53).

F11: Open market sales reported on this line occurred at a weighted average price of $184.42 (range $184.18 to $184.71).

F12: The option vests in 16 quarterly installments from 1/4/2016.

F13: The option vests in 16 quarterly installments from 7/12/2016.